HAMP and metabolic dysfunction-associated steatotic liver disease: In NAFLD, possibly due to a decrease in TSAT, the liver reduces hepcidin mRNA expression in response to this change, reducing ferroportin degradation, allowing more iron to be transported into the blood, and increasing iron bioavailability [17, 75].